Skip to content

Identification of risk factors for diabetes, heart and renal disease

Evaluation of risk factors in the development of type 2 diabetes and cardiovascular disease in a young urban population in Sri Lanka

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
SLCTR
Registry ID
SLCTR/2008/003
Enrollment
Unknown
Registered
2008-03-28
Start date
2007-08-16
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Risk factors for cardiovascular disease

Interventions

Approximately 25,000 persons between 10-40 years of age from schools, universities and workplaces will be screened by a simple questionnaire sand 5000 with two or more risk factors will be selected fo

Sponsors

Diabetes Association of Sri Lanka
Lead Sponsor
BRIDGES Grant
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Age between 5-40 years, Voluntary participation or parental written consent, Two or more of the following 4 criteria 1. First degree family history of diabetes : Father, mother, brother, sister son or a daughter 2. Physical inactivity-Physical activity/exercises less than 30 minutes continuous per day for less than 3 days a week 3. Body Mass Index (BMI): In 10 to 11 year olds defined as weight for height over the 85th percentile and above 11 years to 16 years the BMI over 85th percentile and above 16 years BMI = 23kg/m2 4. Waist -10-16 years: equal or above 91st percentile (or adult cutoff if lower) and above 16 years: Waist of females ³ 80cm of males 90cm

Exclusion criteria

Exclusion criteria: •Current pregnant state •Diabetics or fasting glucose level >= to 126mg/dl or 2 hour value of >= to 200mg/dl •Blood pressure ³ 140mm systolic Hgor ³ 90mmHg diastolic or on treatment for hypertension •On treatment for dyslipidaemia Ischemic heart disease (angina, MI, angioplasty,CABG), stroke •Diagnosed nephropathy or 50% reduction of initial estimated glomerular filtration rate (EGFR) in subsequent analysis

Design outcomes

Primary

MeasureTime frame
The development of Diabetes, Hypertension, Dyslipidaemia needing treatment, Ischaemic heart disease and Reduced e-GFR up to 50% in subsequent analysis in the study and the control group []

Secondary

MeasureTime frame
Subjective: Improvement in diet, exercise Objective: BMI and waist In the study group once in 3 months and control group once a year []

Countries

Sri Lanka

Contacts

Public ContactDr M A Wijesuriya, MD (Cey),FRCP(Lon),FCCP(Cey)

Honorary Director – National Diabetes Centre, Secretary – Diabetes Association of Sri Lanka

dasl@ sltnet.lk2872951/2883318

Outcome results

None listed

Source: SLCTR (via WHO ICTRP) · Data processed: Aug 9, 2026